New tools for antigen delivery to the MHC class I pathway

被引：82

作者：

Morón, G ^{[1
]}

Dadaglio, G ^{[1
]}

Leclerc, C ^{[1
]}

机构：

[1] Inst Pasteur, INSERM E0352, Unite Biol Regulat Immunitaires, F-75724 Paris 15, France

来源：

TRENDS IN IMMUNOLOGY | 2004年 / 25卷 / 02期

关键词：

D O I：

10.1016/j.it.2003.11.008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

At the beginning of this new millennium, pathogens and cancer remain the leading causes of death worldwide. The development of vaccines to prevent diseases for which no vaccine currently exists, such as AIDS or malaria, or to treat chronic infections or cancers, as well as the improvement of efficacy and safety of existing vaccines, remains a high priority. In most cases, the development of such vaccines requires strategies capable of stimulating CD8(+) cytotoxic T lymphocytes (CTLs) and thus, to deliver antigen to MHC class I molecules. There exists several different pathways for loading antigenic peptides onto MHC class I molecules, either based on the endogenous cytosolic MHC I pathway or on cross-presentation. The understanding of the relevance of each of these mechanisms in CTL activation will help vaccine design to progress more rationally.

引用

页码：92 / 97

页数：6

共 54 条

[1] Targeting apoptotic tumor cells to FcγR provides efficient and versatile vaccination against tumors by dendritic cells [J].

Akiyama, K ;

Ebihara, S ;

Yada, A ;

Matsumura, K ;

Aiba, S ;

Nukiwa, T ;

Takai, T .

JOURNAL OF IMMUNOLOGY, 2003, 170 (04) :1641-1648

[2] Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].

Albert, ML ;

Sauter, B ;

Bhardwaj, N .

NATURE, 1998, 392 (6671) :86-89

[3] Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].

Albert, ML ;

Pearce, SFA ;

Francisco, LM ;

Sauter, B ;

Roy, P ;

Silverstein, RL ;

Bhardwaj, N .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368

[4] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].

Amara, RR ;

Villinger, F ;

Altman, JD ;

Lydy, SL ;

O'Neil, SP ;

Staprans, SI ;

Montefiori, DC ;

Xu, Y ;

Herndon, JG ;

Wyatt, LS ;

Candido, MA ;

Kozyr, NL ;

Earl, PL ;

Smith, JM ;

Ma, HL ;

Grimm, BD ;

Hulsey, ML ;

Miller, J ;

McClure, HM ;

McNicholl, JM ;

Moss, B ;

Robinson, HL .

SCIENCE, 2001, 292 (5514) :69-74

[5]

BOHM W, 1995, J IMMUNOL, V155, P3313

[6]

Boisgerault Florence, 2002, Expert Rev Vaccines, V1, P101, DOI 10.1586/14760584.1.1.101

[7] Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].

Bonifaz, L ;

Bonnyay, D ;

Mahnke, K ;

Rivera, M ;

Nussenzweig, MC ;

Steinman, RM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638

[8] Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector [J].

Carbonetti, NH ;

Tuskan, RG ;

Lewis, GK .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (09) :819-827

[9] Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway [J].

Carbonetti, NH ;

Irish, TJ ;

Chen, CH ;

O'Connell, CB ;

Hadley, GA ;

McNamara, U ;

Tuskan, RG ;

Lewis, GK .

INFECTION AND IMMUNITY, 1999, 67 (02) :602-607

[10] Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway [J].

de Haan, L ;

Hearn, AR ;

Rivett, AJ ;

Hirst, TR .

INFECTION AND IMMUNITY, 2002, 70 (06) :3249-3258

← 1 2 3 4 5 6 →